STVNNYSESurgical & Medical Instruments & Apparatus
Stevanato Group S.p.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026
$19.02+0.12 (+0.63%)
Close on Oct 19, 2026
Stevanato Group S.p.A. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Total Segments | €1.32B | €1.30B | €1.25B | €1.10B | €914.03M | €719.46M | €583.05M | 111.4% | +2.0% |
| Biopharmaceutical and Diagnostic Solutions | €1.04B | €937.78M | €881.34M | €801.24M | €695.17M | €566.03M | €455.92M | 87.7% | +10.9% |
| Engineering | €281.01M | €357.64M | €372.81M | €299.50M | €218.86M | €153.43M | €127.12M | 23.7% | -21.4% |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | YoY |
|---|---|---|---|---|---|---|---|---|
| Total Segments | €229.76M | €198.73M | €241.19M | €223.86M | €171.96M | €119.24M | €78.75M | +15.6% |
| Biopharmaceutical and Diagnostic Solutions | €220.43M | €165.64M | €187.58M | €182.58M | €149.06M | €102.64M | €68.74M | +33.1% |
| Engineering | €9.33M | €33.10M | €53.62M | €41.28M | €22.90M | €16.59M | €10.01M | -71.8% |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| High-Value Solutions | €546.37M | €422.35M | €366.43M | €293.23M | €207.82M | €146.33M | €90.70M | 46.1% | +29.4% |
| Other Containment and Delivery Solutions | €491.80M | €511.39M | €512.86M | €506.42M | €486.22M | €418.60M | €364.34M | 41.5% | -3.8% |
| Revenue from Engineering | €148.11M | €170.29M | €206.07M | €184.03M | €149.88M | €97.11M | €81.50M | 12.5% | -13.0% |
| Sale of Residential Flat | – | – | – | – | – | – | €412.00K | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| EMEA | €690.34M | €667.83M | €634.05M | €599.71M | €493.47M | €398.14M | €322.82M | 58.2% | +3.4% |
| North America | €362.06M | €308.95M | €317.54M | €250.84M | €206.96M | €174.92M | €132.44M | 30.5% | +17.2% |
| APAC | €101.48M | €96.24M | €102.90M | €100.26M | €117.75M | €67.14M | €55.52M | 8.6% | +5.4% |
| Italy | €93.33M | €72.07M | €77.84M | – | – | – | – | 7.9% | +29.5% |
| South America | €32.40M | €31.02M | €30.87M | €32.87M | €25.74M | €21.84M | €25.76M | 2.7% | +4.4% |
From the segment and revenue-disaggregation notes of Stevanato Group S.p.A.'s 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.